Thrombin generation in patients with cirrhosis: The role of platelets

Armando Tripodi, Massimo Primignani, Veena Chantarangkul, Marigrazia Clerici, Alessandra Dell'Era, Federica Fabris, Francesco Salerno, Pier Mannuccio Mannucci – 26 July 2006 – Coagulation factor defects, thrombocytopenia, and thrombocytopathy are associated with cirrhosis. However, bleeding in patients who have cirrhosis does not entirely correlate with abnormal coagulation tests.

HCV RNA detection by TMA during the hepatitis C antiviral long‐term treatment against cirrhosis (Halt‐C) trial

Chihiro Morishima, Timothy R. Morgan, James E. Everhart, Elizabeth C. Wright, Mitchell L. Shiffman, Gregory T. Everson, Karen L. Lindsay, Anna S. F. Lok, Herbert L. Bonkovsky, Adrian M. Di Bisceglie, William M. Lee, Jules L. Dienstag, Marc G. Ghany, David R. Gretch, HALT‐C Trial Group – 26 July 2006 – For making treatment decisions related to chronic hepatitis C, the utility of HCV RNA tests with increased sensitivity has not been defined. Prior interferon nonresponders with advanced fibrosis (n = 1,145) were retreated with peginterferon alpha‐2a and ribavirin.

The liver X‐receptor alpha controls hepatic expression of the human bile acid–glucuronidating UGT1A3 enzyme in human cells and transgenic mice

Mélanie Verreault, Kathy Senekeo‐Effenberger, Jocelyn Trottier, Jessica A. Bonzo, Julie Bélanger, Jenny Kaeding, Bart Staels, Patrick Caron, Robert H. Tukey, Olivier Barbier – 26 July 2006 – Glucuronidation, an important bile acid detoxification pathway, is catalyzed by enzymes belonging to the UDP‐glucuronosyltransferase (UGT) family. Among UGT enzymes, UGT1A3 is considered the major human enzyme for the hepatic C24‐glucuronidation of the primary chenodeoxycholic (CDCA) and secondary lithocholic (LCA) bile acids.

Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection

Atsushi Ozasa, Yasuhito Tanaka, Etsuro Orito, Masaya Sugiyama, Jong‐Hon Kang, Shuhei Hige, Tomoyuki Kuramitsu, Kazuyuki Suzuki, Eiji Tanaka, Shunichi Okada, Hajime Tokita, Yasuhiro Asahina, Kazuaki Inoue, Shinichi Kakumu, Takeshi Okanoue, Yoshikazu Murawaki, Keisuke Hino, Morikazu Onji, Hiroshi Yatsuhashi, Hiroshi Sakugawa, Yuzo Miyakawa, Ryuzo Ueda, Masashi Mizokami – 26 July 2006 – The outcome of acute hepatitis B virus (HBV) infection is variable, influenced by host and viral factors.

Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: A report of 2 cases and review of the literature

Federico Aucejo, Charles Miller, David Vogt, Bijan Eghtesad, Shunichi Nakagawa, James K. Stoller – 25 July 2006 – Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are distinct clinical entities that may complicate liver disease. Although HPS and PPHTN are different, several reports describe 6 patients in whom both conditions have occurred, either concurrently or sequentially, sometimes with the onset of PPHTN after liver transplantation.

Subscribe to